To determine if MYCN expression synergizes with Rb1 loss to drive a molecular program associated with NEPC, we performed bulk RNA-seq on histologically distinct tumor foci ranging from adenocarcinoma to NEPC (Fig. 2a). Here, RB1 is linked to neoplasm.